{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:34:34Z","timestamp":1790739274175,"version":"4.1.0"},"publisher-location":"Cham","reference-count":169,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030220044","type":"print"},{"value":"9783030220051","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/164_2019_233","type":"book-chapter","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T05:03:08Z","timestamp":1561352588000},"page":"207-234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease"],"prefix":"10.1007","author":[{"given":"Tim","family":"van Zutphen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde D.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent W.","family":"Bloks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Freark","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W.","family":"Jonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folkert","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"key":"233_CR1","doi-asserted-by":"publisher","first-page":"36759","DOI":"10.1074\/jbc.M110.166231","volume":"285","author":"M Abdelkarim","year":"2010","unstructured":"Abdelkarim M, Caron S, Duhem C et al (2010) The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt\/beta-catenin pathways. J Biol Chem 285:36759\u201336767","journal-title":"J Biol Chem"},{"key":"233_CR2","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1016\/j.bmcl.2010.06.084","volume":"20","author":"U Abel","year":"2010","unstructured":"Abel U, Schl\u00fcter T, Schulz A et al (2010) Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists. Bioorg Med Chem Lett 20:4911\u20134917","journal-title":"Bioorg Med Chem Lett"},{"key":"233_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.2040-1124.2011.00184.x","volume":"3","author":"B Ahr\u00e9n","year":"2012","unstructured":"Ahr\u00e9n B (2012) DPP-4 inhibition and islet function. J Diabetes Investig 3:3\u201310","journal-title":"J Diabetes Investig"},{"key":"233_CR4","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1053\/j.gastro.2018.11.017","volume":"156","author":"VL Albaugh","year":"2018","unstructured":"Albaugh VL, Banan B, Antoun J et al (2018) Role of bile acids and GLP-1 in mediating the metabolic improvements of bariatric surgery. Gastroenterology 156:1041\u20131051.e4","journal-title":"Gastroenterology"},{"key":"233_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s40495-017-0085-2","volume":"3","author":"LE Armstrong","year":"2017","unstructured":"Armstrong LE, Guo GL (2017) Role of FXR in liver inflammation during nonalcoholic steatohepatitis. Curr Pharmacol Rep 3:92\u2013100","journal-title":"Curr Pharmacol Rep"},{"key":"233_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/1756-0500-5-461","volume":"5","author":"R Attinkara","year":"2012","unstructured":"Attinkara R, Mwinyi J, Truninger K et al (2012) Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease. BMC Res Notes 5:461","journal-title":"BMC Res Notes"},{"key":"233_CR7","doi-asserted-by":"publisher","first-page":"G937","DOI":"10.1152\/ajpgi.00441.2011","volume":"302","author":"N Balasubramaniyan","year":"2012","unstructured":"Balasubramaniyan N, Ananthanarayanan M, Suchy FJ (2012) Direct methylation of FXR by Set7\/9, a lysine methyltransferase, regulates the expression of FXR target genes. Am J Physiol Gastrointest Liver Physiol 302:G937\u2013G947","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"233_CR8","doi-asserted-by":"publisher","first-page":"13850","DOI":"10.1074\/jbc.M112.443937","volume":"288","author":"N Balasubramaniyan","year":"2013","unstructured":"Balasubramaniyan N, Luo Y, Sun AQ et al (2013) SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes. J Biol Chem 288:13850\u201313862","journal-title":"J Biol Chem"},{"key":"233_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1210\/en.2016-1577","volume":"158","author":"N Becares","year":"2017","unstructured":"Becares N, Gage MC, Pineda-Torra I (2017) Posttranslational modifications of lipid-activated nuclear receptors: focus on metabolism. Endocrinology 158:213\u2013225","journal-title":"Endocrinology"},{"key":"233_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3389\/fendo.2014.00230","volume":"5","author":"F Benhamed","year":"2015","unstructured":"Benhamed F, Filhoulaud G, Caron S et al (2015) O-GlcNAcylation links ChREBP and FXR to glucose-sensing. Front Endocrinol 5:230","journal-title":"Front Endocrinol"},{"key":"233_CR11","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1126\/science.290.5497.1771","volume":"290","author":"KE Berge","year":"2000","unstructured":"Berge KE, Tian H, Graf GA et al (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290:1771\u20131775","journal-title":"Science"},{"key":"233_CR12","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/hep.26710","volume":"59","author":"W Berrabah","year":"2014","unstructured":"Berrabah W, Aumercier P, Gheeraert C et al (2014) Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR). Hepatology 59:2022\u20132033","journal-title":"Hepatology"},{"key":"233_CR13","doi-asserted-by":"publisher","first-page":"G404","DOI":"10.1152\/ajpgi.00188.2018","volume":"316","author":"A Bertolini","year":"2019","unstructured":"Bertolini A, van de Peppel IP, Doktorova-Demmin M et al (2019) Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol. Am J Physiol Gastrointest Liver Physiol 316:G404\u2013G411","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"233_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/jmcb\/mjx009","volume":"9","author":"S Bilodeau","year":"2017","unstructured":"Bilodeau S, Caron V, Gagnon J et al (2017) A CK2-RNF4 interplay coordinates non-canonical SUMOylation and degradation of nuclear receptor FXR. J Mol Cell Biol 9:195\u2013208","journal-title":"J Mol Cell Biol"},{"key":"233_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/ajcn\/28.2.119","volume":"28","author":"HJ Binder","year":"1975","unstructured":"Binder HJ, Filburn B, Floch M (1975) Bile acid inhibition of intestinal anaerobic organisms. Am J Clin Nutr 28:119\u2013125","journal-title":"Am J Clin Nutr"},{"key":"233_CR16","doi-asserted-by":"publisher","first-page":"e115028","DOI":"10.1371\/journal.pone.0115028","volume":"9","author":"M Boesjes","year":"2014","unstructured":"Boesjes M, Bloks VW, Hageman J et al (2014) Hepatic farnesoid X-receptor isoforms \u03b12 and \u03b14 differentially modulate bile salt and lipoprotein metabolism in mice. PLoS One 9:e115028","journal-title":"PLoS One"},{"key":"233_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.tem.2012.10.004","volume":"24","author":"B Bonamassa","year":"2013","unstructured":"Bonamassa B, Moschetta A (2013) Atherosclerosis: lessons from LXR and the intestine. Trends Endocrinol Metab 24:120\u2013128","journal-title":"Trends Endocrinol Metab"},{"key":"233_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147772","volume":"11","author":"Y Bonde","year":"2016","unstructured":"Bonde Y, Eggertsen G, Rudling M (2016) Mice abundant in muricholic bile acids show resistance to dietary induced steatosis, weight gain, and to impaired glucose metabolism. PLoS One 11:e0147772","journal-title":"PLoS One"},{"key":"233_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0022-2275(20)33370-8","volume":"40","author":"MS Bosner","year":"1999","unstructured":"Bosner MS, Lange LG, Stenson WF (1999) Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J Lipid Res 40:302\u2013308","journal-title":"J Lipid Res"},{"key":"233_CR20","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/hep.23831","volume":"52","author":"G Brufau","year":"2010","unstructured":"Brufau G, Stellaard F, Prado K et al (2010) Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism. Hepatology 52:1455\u20131464","journal-title":"Hepatology"},{"key":"233_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ng0398-219","volume":"18","author":"LN Bull","year":"1998","unstructured":"Bull LN, van Eijk MJ, Pawlikowska L et al (1998) A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 18:219\u2013224","journal-title":"Nat Genet"},{"key":"233_CR22","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.15252\/embj.201695500","volume":"36","author":"S Byun","year":"2017","unstructured":"Byun S, Kim YC, Zhang Y et al (2017) A postprandial FGF19-SHP-LSD1 regulatory axis mediates epigenetic repression of hepatic autophagy. EMBO J 36:1755\u20131769","journal-title":"EMBO J"},{"key":"233_CR23","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.bbadis.2017.09.019","volume":"1864","author":"M Cariello","year":"2018","unstructured":"Cariello M, Piccinin E, Garcia-Irigoyen O et al (2018) Nuclear receptor FXR, bile acids and liver damage: introducing the progressive familial intrahepatic cholestasis with FXR mutations. Biochim Biophys Acta Mol basis Dis 1864:1308\u20131318","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"233_CR24","doi-asserted-by":"publisher","first-page":"11039","DOI":"10.1074\/jbc.M510258200","volume":"281","author":"B Cariou","year":"2006","unstructured":"Cariou B, van Harmelen K, Duran-Sandoval D et al (2006) The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem 281:11039\u201311049","journal-title":"J Biol Chem"},{"key":"233_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169331","volume":"12","author":"LJ Ceulemans","year":"2017","unstructured":"Ceulemans LJ, Verbeke L, Decuypere J-P et al (2017) Farnesoid X receptor activation attenuates intestinal ischemia reperfusion injury in rats. PLoS One 12:e0169331","journal-title":"PLoS One"},{"key":"233_CR26","first-page":"1756283","volume":"4","author":"G Charach","year":"2017","unstructured":"Charach G, Argov O, Geiger K et al (2017) Diminished bile acids excretion is a risk factor for coronary artery disease: 20-year follow up and long-term outcome. Ther Adv Gastroenterol 4:1756283\u20137743420","journal-title":"Ther Adv Gastroenterol"},{"key":"233_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1124\/jpet.110.166892","volume":"334","author":"L Chen","year":"2010","unstructured":"Chen L, McNulty J, Anderson D et al (2010) Cholestyramine reverses hyperglycemia and enhances glucose-stimulated glucagon-like peptide 1 release in Zucker diabetic fatty rats. J Pharmacol Exp Ther 334:164\u2013170","journal-title":"J Pharmacol Exp Ther"},{"key":"233_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1152\/ajpendo.00323.2011","volume":"302","author":"L Chen","year":"2012","unstructured":"Chen L, Yao X, Young A et al (2012) Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes. Am J Physiol Endocrinol Metab 302:68\u201376","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"233_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.psychres.2018.04.025","volume":"264","author":"WG Chen","year":"2018","unstructured":"Chen WG, Zheng JX, Xu X et al (2018) Hippocampal FXR plays a role in the pathogenesis of depression: a preliminary study based on lentiviral gene modulation. Psychiatry Res 264:374\u2013379","journal-title":"Psychiatry Res"},{"key":"233_CR30","doi-asserted-by":"publisher","first-page":"25572","DOI":"10.18632\/oncotarget.25385","volume":"9","author":"K Cheng","year":"2018","unstructured":"Cheng K, Metry M, Felton J et al (2018) Diminished gallbladder filling, increased fecal bile acids, and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15-deficient mice. Oncotarget 9:25572\u201325585","journal-title":"Oncotarget"},{"key":"233_CR31","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm1501","volume":"12","author":"M Choi","year":"2006","unstructured":"Choi M, Moschetta A, Bookout AL et al (2006) Identification of a hormonal basis for gallbladder filling. Nat Med 12:1253\u20131255","journal-title":"Nat Med"},{"key":"233_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1053\/j.gastro.2018.07.028","volume":"155","author":"OI Coleman","year":"2018","unstructured":"Coleman OI, Lobner EM, Bierwirth S et al (2018) Activated ATF6 induces intestinal dysbiosis and innate immune response to promote colorectal tumorigenesis. Gastroenterology 155:1539\u20131552","journal-title":"Gastroenterology"},{"key":"233_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13046-018-0781-8","volume":"37","author":"G Cui","year":"2018","unstructured":"Cui G, Martin RC, Jin H et al (2018) Up-regulation of FGF15\/19 signaling promotes hepatocellular carcinoma in the background of fatty liver. J Exp Clin Cancer Res 37:136","journal-title":"J Exp Clin Cancer Res"},{"key":"233_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000450987","volume":"35","author":"PA Dawson","year":"2017","unstructured":"Dawson PA (2017) Roles of Ileal ASBT and OST\u03b1-OST\u03b2 in regulating bile acid signaling. Dig Dis 35:261\u2013266","journal-title":"Dig Dis"},{"key":"233_CR35","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1053\/j.gastro.2016.12.037","volume":"152","author":"JF de Boer","year":"2017","unstructured":"de Boer JF, Schonewille M, Boesjes M et al (2017) Intestinal farnesoid X receptor controls transintestinal cholesterol excretion in mice. Gastroenterology 152:1126\u20131138","journal-title":"Gastroenterology"},{"key":"233_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tem.2017.11.006","volume":"29","author":"JF de Boer","year":"2018","unstructured":"de Boer JF, Kuipers F, Groen AK (2018) Cholesterol transport revisited: a new turbo mechanism to drive cholesterol excretion. Trends Endocrinol Metab 29:123\u2013133","journal-title":"Trends Endocrinol Metab"},{"key":"233_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.celrep.2014.02.032","volume":"7","author":"C Degirolamo","year":"2014","unstructured":"Degirolamo C, Rainaldi S, Bovenga F et al (2014) Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Rep 7:12\u201318","journal-title":"Cell Rep"},{"key":"233_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/hep.27274","volume":"61","author":"C Degirolamo","year":"2015","unstructured":"Degirolamo C, Modica S, Vacca M et al (2015) Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation. Hepatology 61:161\u2013170","journal-title":"Hepatology"},{"key":"233_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000129252","volume":"25","author":"JW Ding","year":"1993","unstructured":"Ding JW, Andersson R, Soltesz V et al (1993) The role of bile and bile acids in bacterial translocation in obstructive jaundice in rats. Eur Surg Res 25:11\u201319","journal-title":"Eur Surg Res"},{"key":"233_CR40","doi-asserted-by":"publisher","first-page":"890","DOI":"10.2337\/diabetes.53.4.890","volume":"53","author":"D Duran-Sandoval","year":"2004","unstructured":"Duran-Sandoval D, Mautino G, Martin G et al (2004) Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes 53:890\u2013898","journal-title":"Diabetes"},{"key":"233_CR41","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.2337\/dc12-1766","volume":"36","author":"Q Fang","year":"2013","unstructured":"Fang Q, Li H, Song Q et al (2013) Serum fibroblast growth factor 19 levels are decreased in Chinese subjects with impaired fasting glucose and inversely associated with fasting plasma glucose levels. Diabetes Care 36:2810\u20132814","journal-title":"Diabetes Care"},{"key":"233_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.3760","volume":"21","author":"S Fang","year":"2015","unstructured":"Fang S, Suh JM, Reilly SM et al (2015) Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat Med 21:159\u2013165","journal-title":"Nat Med"},{"key":"233_CR43","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S0016-5085(79)80079-7","volume":"77","author":"T Fedorowski","year":"1979","unstructured":"Fedorowski T, Salen G, Tint GS et al (1979) Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria. Gastroenterology 77:1068\u20131073","journal-title":"Gastroenterology"},{"key":"233_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.intimp.2018.11.005","volume":"66","author":"J Fei","year":"2019","unstructured":"Fei J, Fu L, Hu B et al (2019) Obeticholic acid alleviate lipopolysaccharide-induced acute lung injury via its anti-inflammatory effects in mice. Int Immunopharmacol 66:177\u2013184","journal-title":"Int Immunopharmacol"},{"key":"233_CR45","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jcmgh.2018.01.006","volume":"5","author":"CB Ferrebee","year":"2018","unstructured":"Ferrebee CB, Li J, Haywood J et al (2018) Organic solute transporter \u03b1-\u03b2 protects ileal enterocytes from bile acid-induced injury. Cell Mol Gastroenterol Hepatol 5:499\u2013522","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"233_CR46","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1002\/hep.22431","volume":"48","author":"T Frankenberg","year":"2008","unstructured":"Frankenberg T, Miloh T, Chen FY et al (2008) The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor. Hepatology 48:1896\u20131905","journal-title":"Hepatology"},{"key":"233_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036713","volume":"7","author":"DM French","year":"2012","unstructured":"French DM, Lin BC, Wang M et al (2012) Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models. PLoS One 7:e36713","journal-title":"PLoS One"},{"key":"233_CR48","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1053\/j.gastro.2018.08.022","volume":"155","author":"ES Friedman","year":"2018","unstructured":"Friedman ES, Li Y, Shen TD et al (2018) FXR-dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid. Gastroenterology 155:1741\u20131752","journal-title":"Gastroenterology"},{"key":"233_CR49","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1210\/en.2003-1671","volume":"145","author":"L Fu","year":"2004","unstructured":"Fu L, John LM, Adams SH et al (2004) Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 145:2594\u20132603","journal-title":"Endocrinology"},{"key":"233_CR50","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.cmet.2012.03.007","volume":"15","author":"S Fu","year":"2012","unstructured":"Fu S, Watkins SM, Hotamisligil GS (2012) The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab 15:623\u2013634","journal-title":"Cell Metab"},{"key":"233_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1055\/s-0036-1571296","volume":"36","author":"CD Fuchs","year":"2016","unstructured":"Fuchs CD, Traussnigg SA, Trauner M (2016) Nuclear receptor modulation for the treatment of nonalcoholic fatty liver disease. Semin Liver Dis 36:69\u201386","journal-title":"Semin Liver Dis"},{"key":"233_CR52","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2010.212159","volume":"60","author":"RM Gadaleta","year":"2011","unstructured":"Gadaleta RM, van Erpecum KJ, Oldenburg B et al (2011a) Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut 60:463\u2013472","journal-title":"Gut"},{"key":"233_CR53","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.bbadis.2011.04.005","volume":"1812","author":"RM Gadaleta","year":"2011","unstructured":"Gadaleta RM, Oldenburg B, Willemsen ECL et al (2011b) Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-\u03baB signaling in the intestine. Biochim Biophys Acta Mol basis Dis 1812:851\u2013858","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"233_CR54","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1074\/jbc.M115.694323","volume":"291","author":"Z Gai","year":"2016","unstructured":"Gai Z, Gui T, Hiller C et al (2016) Farnesoid X receptor protects against kidney injury in uninephrectomized obese mice. J Biol Chem 291:2397\u20132411","journal-title":"J Biol Chem"},{"key":"233_CR55","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1210\/me.2008-0092","volume":"22","author":"G Gineste","year":"2008","unstructured":"Gineste G, Sirvent A, Paumelle R et al (2008) Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activity. Mol Endocrinol 22:2433\u20132447","journal-title":"Mol Endocrinol"},{"key":"233_CR56","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","volume":"6","author":"B Goodwin","year":"2000","unstructured":"Goodwin B, Jones SA, Price RR et al (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517\u2013526","journal-title":"Mol Cell"},{"key":"233_CR57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.gene.2015.01.046","volume":"560","author":"MA Gray","year":"2015","unstructured":"Gray MA, Squires EJ (2015) Investigation of the dominant positive effect of porcine farnesoid X receptor (FXR) splice variant 1. Gene 560:71\u201376","journal-title":"Gene"},{"key":"233_CR58","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1016\/j.celrep.2018.07.068","volume":"24","author":"CY Han","year":"2018","unstructured":"Han CY, Rho HS, Kim A et al (2018) FXR inhibits endoplasmic reticulum stress-induced NLRP3 inflammasome in hepatocytes and ameliorates liver injury. Cell Rep 24:2985\u20132999","journal-title":"Cell Rep"},{"key":"233_CR59","doi-asserted-by":"publisher","first-page":"S244","DOI":"10.2337\/dc11-s237","volume":"34","author":"Y Handelsman","year":"2011","unstructured":"Handelsman Y (2011) Role of bile acid sequestrants in the treatment of type 2 diabetes. Diabetes Care 34:S244\u2013S250","journal-title":"Diabetes Care"},{"key":"233_CR60","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S0140-6736(18)30474-4","volume":"391","author":"SA Harrison","year":"2018","unstructured":"Harrison SA, Rinella ME, Abdelmalek MF et al (2018) NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 391:1174\u20131185","journal-title":"Lancet"},{"key":"233_CR61","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/MNH.0000000000000374","volume":"27","author":"M Herman-Edelstein","year":"2018","unstructured":"Herman-Edelstein M, Weinstein T, Levi M (2018) Bile acid receptors and the kidney. Curr Opin Nephrol Hypertens 27:56\u201362","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"233_CR62","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0022-2275(20)38331-0","volume":"30","author":"DM Heuman","year":"1989","unstructured":"Heuman DM (1989) Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 30:719\u2013730","journal-title":"J Lipid Res"},{"key":"233_CR63","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40168-016-0213-y","volume":"5","author":"CJ Hill","year":"2017","unstructured":"Hill CJ, Lynch DB, Murphy K et al (2017) Evolution of gut microbiota composition from birth to 24\u00a0weeks in the INFANTMET cohort. Microbiome 5:4","journal-title":"Microbiome"},{"key":"233_CR64","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1194\/jlr.R049437","volume":"55","author":"AF Hofmann","year":"2014","unstructured":"Hofmann AF, Hagey LR (2014) Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades. J Lipid Res 55:1553\u20131595","journal-title":"J Lipid Res"},{"key":"233_CR65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0378-1119(02)00557-7","volume":"290","author":"RM Huber","year":"2002","unstructured":"Huber RM, Murphy K, Miao B et al (2002) Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters. Gene 290:35\u201343","journal-title":"Gene"},{"key":"233_CR66","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","volume":"2","author":"T Inagaki","year":"2005","unstructured":"Inagaki T, Choi M, Moschetta A et al (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2:217\u2013225","journal-title":"Cell Metab"},{"key":"233_CR67","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1073\/pnas.0509592103","volume":"103","author":"T Inagaki","year":"2006","unstructured":"Inagaki T, Moschetta A, Lee Y-K et al (2006) Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci 103:3920\u20133925","journal-title":"Proc Natl Acad Sci"},{"key":"233_CR68","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cmet.2016.10.001","volume":"24","author":"L Jakulj","year":"2016","unstructured":"Jakulj L, van Dijk TH, de Boer JF et al (2016) Transintestinal cholesterol transport is active in mice and humans and controls ezetimibe-induced fecal neutral sterol excretion. Cell Metab 24:783\u2013794","journal-title":"Cell Metab"},{"key":"233_CR69","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1172\/JCI76738","volume":"125","author":"C Jiang","year":"2015","unstructured":"Jiang C, Xie C, Li F et al (2015a) Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J Clin Invest 125:386\u2013402","journal-title":"J Clin Invest"},{"key":"233_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10166","volume":"6","author":"C Jiang","year":"2015","unstructured":"Jiang C, Xie C, Lv Y et al (2015b) Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. Nat Commun 6:10166","journal-title":"Nat Commun"},{"key":"233_CR71","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev-food-041715-033159","volume":"7","author":"SA Joyce","year":"2016","unstructured":"Joyce SA, Gahan CGM (2016) Bile acid modifications at the microbe-host interface: potential for nutraceutical and pharmaceutical interventions in host health. Annu Rev Food Sci Technol 7:313\u2013333","journal-title":"Annu Rev Food Sci Technol"},{"key":"233_CR72","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.cmet.2015.05.004","volume":"21","author":"T Katafuchi","year":"2015","unstructured":"Katafuchi T, Esterh\u00e1zy D, Lemoff A et al (2015) Detection of FGF15 in plasma by stable isotope standards and capture by anti-peptide antibodies and targeted mass spectrometry. Cell Metab 21:898\u2013904","journal-title":"Cell Metab"},{"key":"233_CR73","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cmet.2009.09.009","volume":"10","author":"JK Kemper","year":"2009","unstructured":"Kemper JK, Xiao Z, Ponugoti B et al (2009) FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab 10:392\u2013404","journal-title":"Cell Metab"},{"key":"233_CR74","doi-asserted-by":"publisher","first-page":"140","DOI":"10.5625\/lar.2018.34.4.140","volume":"34","author":"H Kim","year":"2018","unstructured":"Kim H, Fang S (2018) Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis. Lab Anim Res 34:140\u2013146","journal-title":"Lab Anim Res"},{"key":"233_CR75","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","volume":"48","author":"I Kim","year":"2007","unstructured":"Kim I, Ahn SH, Inagaki T et al (2007) Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 48:2664\u20132672","journal-title":"J Lipid Res"},{"key":"233_CR76","doi-asserted-by":"publisher","first-page":"184","DOI":"10.15252\/embj.201489527","volume":"34","author":"DH Kim","year":"2014","unstructured":"Kim DH, Xiao Z, Kwon S et al (2014) A dysregulated acetyl\/SUMO switch of FXR promotes hepatic inflammation in obesity. EMBO J 34:184\u2013199","journal-title":"EMBO J"},{"key":"233_CR1000","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/hep.29199","volume":"66","author":"KH Kim","year":"2017","unstructured":"Kim KH, Choi S, Zhou Y et al (2017) Hepatic FXR\/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice. Hepatology 66:498\u2013509","journal-title":"Hepatology"},{"key":"233_CR77","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1053\/j.gastro.2018.11.061","volume":"156","author":"Y-C Kim","year":"2018","unstructured":"Kim Y-C, Byun S, Seok S et al (2018) Small heterodimer partner and fibroblast growth factor 19 inhibit expression of NPC1L1 in mouse intestine and cholesterol absorption. Gastroenterology 156:1052\u20131065","journal-title":"Gastroenterology"},{"key":"233_CR78","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1126\/science.1198363","volume":"331","author":"S Kir","year":"2011","unstructured":"Kir S, Beddow SA, Samuel VT et al (2011) FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 331:1621\u20131624","journal-title":"Science"},{"key":"233_CR79","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/hep.25740","volume":"56","author":"B Kong","year":"2012","unstructured":"Kong B, Wang L, Chiang JYL et al (2012) Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology 56:1034\u20131043","journal-title":"Hepatology"},{"key":"233_CR80","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nrendo.2014.60","volume":"10","author":"F Kuipers","year":"2014","unstructured":"Kuipers F, Bloks VW, Groen AK (2014) Beyond intestinal soap \u2013 bile acids in metabolic control. Nat Rev Endocrinol 10:488\u2013498","journal-title":"Nat Rev Endocrinol"},{"key":"233_CR81","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cmet.2017.09.005","volume":"26","author":"T Lan","year":"2017","unstructured":"Lan T, Morgan DA, Rahmouni K et al (2017) FGF19, FGF21, and an FGFR1\/\u03b2-Klotho-activating antibody act on the nervous system to regulate body weight and glycemia. Cell Metab 26:709\u2013718","journal-title":"Cell Metab"},{"key":"233_CR82","doi-asserted-by":"publisher","first-page":"527","DOI":"10.18632\/aging.100184","volume":"2","author":"J Lee","year":"2010","unstructured":"Lee J, Kemper JK (2010) Controlling SIRT1 expression by microRNAs in health and metabolic disease. Aging 2:527\u2013534","journal-title":"Aging"},{"key":"233_CR1001","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/hep.25609","volume":"56","author":"J Lee","year":"2012","unstructured":"Lee J, Seok S, Yu P et al (2012) Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice. Hepatology 56:108\u2013117","journal-title":"Hepatology"},{"key":"233_CR83","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature13961","volume":"516","author":"JM Lee","year":"2014","unstructured":"Lee JM, Wagner M, Xiao R et al (2014) Nutrient-sensing nuclear receptors coordinate autophagy. Nature 516:112\u2013115","journal-title":"Nature"},{"key":"233_CR84","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00010.2008","volume":"89","author":"P Lefebvre","year":"2009","unstructured":"Lefebvre P, Cariou B, Lien F et al (2009) Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 89:147\u2013191","journal-title":"Physiol Rev"},{"key":"233_CR85","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1038\/ncomms3384","volume":"4","author":"F Li","year":"2013","unstructured":"Li F, Jiang C, Krausz KW et al (2013) Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Commun 4:2384","journal-title":"Nat Commun"},{"key":"233_CR86","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1172\/JCI68815","volume":"124","author":"F Lien","year":"2014","unstructured":"Lien F, Berthier A, Bouchaert E et al (2014) Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk. J Clin Invest 124:1037\u20131051","journal-title":"J Clin Invest"},{"key":"233_CR87","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/hep.29815","volume":"68","author":"X Liu","year":"2018","unstructured":"Liu X, Guo GL, Kong B et al (2018) Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice. Hepatology 68:304\u2013316","journal-title":"Hepatology"},{"key":"233_CR88","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S1097-2765(00)00050-2","volume":"6","author":"TT Lu","year":"2000","unstructured":"Lu TT, Makishima M, Repa JJ et al (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6:507\u2013515","journal-title":"Mol Cell"},{"key":"233_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193824","volume":"13","author":"L Luo","year":"2018","unstructured":"Luo L, Aubrecht J, Li D et al (2018) Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans. PLoS One 13:e0193824","journal-title":"PLoS One"},{"key":"233_CR90","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","volume":"284","author":"M Makishima","year":"1999","unstructured":"Makishima M, Okamoto AY, Repa JJ et al (1999) Identification of a nuclear receptor for bile acids. Science 284:1362\u20131365","journal-title":"Science"},{"key":"233_CR91","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1124\/jpet.108.145409","volume":"328","author":"RRM Maran","year":"2009","unstructured":"Maran RRM, Thomas A, Roth M et al (2009) Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development. J Pharmacol Exp Ther 328:469\u2013477","journal-title":"J Pharmacol Exp Ther"},{"key":"233_CR92","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","volume":"298","author":"T Maruyama","year":"2002","unstructured":"Maruyama T, Miyamoto Y, Nakamura T et al (2002) Identification of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun 298:714\u2013719","journal-title":"Biochem Biophys Res Commun"},{"key":"233_CR93","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.pharmthera.2018.06.009","volume":"191","author":"V Massafra","year":"2018","unstructured":"Massafra V, Pellicciari R, Gioiello A et al (2018) Progress and challenges of selective farnesoid X receptor modulation. Pharmacol Ther 191:162\u2013177","journal-title":"Pharmacol Ther"},{"key":"233_CR94","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2407-12-56","volume":"12","author":"S Miura","year":"2012","unstructured":"Miura S, Mitsuhashi N, Shimizu H et al (2012) Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma. BMC Cancer 12:56","journal-title":"BMC Cancer"},{"key":"233_CR95","doi-asserted-by":"publisher","first-page":"9589","DOI":"10.1158\/0008-5472.CAN-08-1791","volume":"68","author":"S Modica","year":"2008","unstructured":"Modica S, Murzilli S, Salvatore L et al (2008) Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res 68:9589\u20139594","journal-title":"Cancer Res"},{"key":"233_CR96","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/j.gastro.2011.10.028","volume":"142","author":"S Modica","year":"2012","unstructured":"Modica S, Petruzzelli M, Bellafante E et al (2012) Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Gastroenterology 142:355\u2013365","journal-title":"Gastroenterology"},{"key":"233_CR97","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1172\/JCI70710","volume":"123","author":"GJ Morton","year":"2013","unstructured":"Morton GJ, Matsen ME, Bracy DP et al (2013) FGF19 action in the brain induces insulin-independent glucose lowering. J Clin Invest 123:4799\u20134808","journal-title":"J Clin Invest"},{"key":"233_CR98","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nri3738","volume":"14","author":"AM Mowat","year":"2014","unstructured":"Mowat AM, Agace WW (2014) Regional specialization within the intestinal immune system. Nat Rev Immunol 14:667\u2013685","journal-title":"Nat Rev Immunol"},{"key":"233_CR99","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.jhep.2014.12.034","volume":"62","author":"M Mueller","year":"2015","unstructured":"Mueller M, Thorell A, Claudel T et al (2015) Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity. J Hepatol 62:1398\u20131404","journal-title":"J Hepatol"},{"key":"233_CR100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152207","volume":"11","author":"T Nakano","year":"2016","unstructured":"Nakano T, Inoue I, Takenaka Y et al (2016) Ezetimibe promotes brush border membrane-to-lumen cholesterol efflux in the small intestine. PLoS One 11:e0152207","journal-title":"PLoS One"},{"key":"233_CR101","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","volume":"385","author":"BA Neuschwander-Tetri","year":"2015","unstructured":"Neuschwander-Tetri BA, Loomba R, Sanyal AJ et al (2015) Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 385:956\u2013965","journal-title":"Lancet"},{"key":"233_CR102","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens F, Andreone P, Mazzella G et al (2016) A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med 375:631\u2013643","journal-title":"N Engl J Med"},{"key":"233_CR103","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1016\/S0002-9440(10)61177-7","volume":"160","author":"K Nicholes","year":"2002","unstructured":"Nicholes K, Guillet S, Tomlinson E et al (2002) A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. Am J Pathol 160:2295\u20132307","journal-title":"Am J Pathol"},{"key":"233_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023745","volume":"6","author":"RM Nijmeijer","year":"2011","unstructured":"Nijmeijer RM, Gadaleta RM, van Mil SWC et al (2011) Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease. PLoS One 6:e23745","journal-title":"PLoS One"},{"key":"233_CR105","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1128\/MCB.23.3.864-872.2003","volume":"23","author":"K Otte","year":"2003","unstructured":"Otte K, Kranz H, Kober I et al (2003) Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterol. Mol Cell Biol 23:864\u2013872","journal-title":"Mol Cell Biol"},{"key":"233_CR106","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jhep.2015.04.030","volume":"63","author":"C Out","year":"2015","unstructured":"Out C, Patankar JV, Doktorova M et al (2015) Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4. J Hepatol 63:697\u2013704","journal-title":"J Hepatol"},{"key":"233_CR107","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nrd2199","volume":"5","author":"JP Overington","year":"2006","unstructured":"Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5:993\u2013996","journal-title":"Nat Rev Drug Discov"},{"key":"233_CR108","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","volume":"284","author":"DJ Parks","year":"1999","unstructured":"Parks DJ, Blanchard SG, Bledsoe RK et al (1999) Bile acids: natural ligands for an orphan nuclear receptor. Science 284:1365\u20131368","journal-title":"Science"},{"key":"233_CR109","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/gutjnl-2015-310283","volume":"66","author":"A Pars\u00e9us","year":"2017","unstructured":"Pars\u00e9us A, Sommer N, Sommer F et al (2017) Microbiota-induced obesity requires farnesoid X receptor. Gut 66:429\u2013437","journal-title":"Gut"},{"key":"233_CR110","doi-asserted-by":"publisher","first-page":"11055","DOI":"10.1074\/jbc.M117.784322","volume":"292","author":"P Pathak","year":"2017","unstructured":"Pathak P, Liu H, Boehme S et al (2017) Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism. J Biol Chem 292:11055\u201311069","journal-title":"J Biol Chem"},{"key":"233_CR111","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/hep.29857","volume":"68","author":"P Pathak","year":"2018","unstructured":"Pathak P, Xie C, Nichols RG et al (2018) Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Hepatology 68:1574\u20131588","journal-title":"Hepatology"},{"key":"233_CR112","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/dom.12681","volume":"18","author":"R Pencek","year":"2016","unstructured":"Pencek R, Marmon T, Roth JD et al (2016) Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers. Diabetes Obes Metab 18:936\u2013940","journal-title":"Diabetes Obes Metab"},{"key":"233_CR113","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cmet.2011.03.019","volume":"13","author":"MJ Potthoff","year":"2011","unstructured":"Potthoff MJ, Boney-Montoya J, Choi M et al (2011) FGF15\/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1\u03b1 pathway. Cell Metab 13:729\u2013738","journal-title":"Cell Metab"},{"key":"233_CR114","doi-asserted-by":"publisher","first-page":"357ra122","DOI":"10.1126\/scitranslmed.aaf4823","volume":"8","author":"A Rao","year":"2016","unstructured":"Rao A, Kosters A, Mells JE et al (2016) Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet\u2013fed mice. Sci Transl Med 8:357ra122\u2013357ra357","journal-title":"Sci Transl Med"},{"key":"233_CR115","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1093\/carcin\/bgv107","volume":"36","author":"JP Raufman","year":"2015","unstructured":"Raufman JP, Dawson PA, Rao A et al (2015) Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids. Carcinogenesis 36:1193\u20131200","journal-title":"Carcinogenesis"},{"key":"233_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054472","volume":"8","author":"B Renga","year":"2013","unstructured":"Renga B, Mencarelli A, Cipriani S et al (2013) The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation. PLoS One 8:e54472","journal-title":"PLoS One"},{"key":"233_CR117","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nature13135","volume":"509","author":"KK Ryan","year":"2014","unstructured":"Ryan KK, Tremaroli V, Clemmensen C et al (2014) FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 509:183\u2013188","journal-title":"Nature"},{"key":"233_CR118","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin SI, Wahlstr\u00f6m A, Felin J et al (2013) Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17:225\u2013235","journal-title":"Cell Metab"},{"key":"233_CR119","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature13949","volume":"516","author":"S Seok","year":"2014","unstructured":"Seok S, Fu T, Choi SE et al (2014) Transcriptional regulation of autophagy by an FXR-CREB axis. Nature 516:108\u2013111","journal-title":"Nature"},{"key":"233_CR120","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1084\/jem.20171965","volume":"215","author":"H Shapiro","year":"2018","unstructured":"Shapiro H, Kolodziejczyk AA, Halstuch D et al (2018) Bile acids in glucose metabolism in health and disease. J Exp Med 215:383\u2013396","journal-title":"J Exp Med"},{"key":"233_CR121","doi-asserted-by":"publisher","first-page":"E167","DOI":"10.1152\/ajpendo.00416.2016","volume":"313","author":"BG Sj\u00f6berg","year":"2017","unstructured":"Sj\u00f6berg BG, Straniero S, Angelin B et al (2017) Cholestyramine treatment of healthy humans rapidly induces transient hypertriglyceridemia when treatment is initiated. Am J Physiol Endocrinol Metab 313:E167\u2013E174","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"233_CR122","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000450983","volume":"35","author":"D Slijepcevic","year":"2017","unstructured":"Slijepcevic D, van de Graaf SFJ (2017) Bile acid uptake transporters as targets for therapy. Dig Dis 35:251\u2013258","journal-title":"Dig Dis"},{"key":"233_CR123","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/ijo.2016.46","volume":"40","author":"V Spinelli","year":"2016","unstructured":"Spinelli V, Lalloyer F, Baud G et al (2016) Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans. Int J Obes 40:1260\u20131267","journal-title":"Int J Obes"},{"key":"233_CR124","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0016-5085(93)90848-7","volume":"104","author":"GE Stahl","year":"1993","unstructured":"Stahl GE, Mascarenhas MR, Fayer JC et al (1993) Passive jejunal bile salt absorption alters the enterohepatic circulation in immature rats. Gastroenterology 104:163\u2013173","journal-title":"Gastroenterology"},{"key":"233_CR125","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3748\/wjg.v18.i9.923","volume":"18","author":"LK Stenman","year":"2012","unstructured":"Stenman LK, Holma R, Korpela R (2012) High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World J Gastroenterol 18:923\u2013929","journal-title":"World J Gastroenterol"},{"key":"233_CR126","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/labinvest.2010.107","volume":"90","author":"JH Stroeve","year":"2010","unstructured":"Stroeve JH, Brufau G, Stellaard F et al (2010) Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice. Lab Investig 90:1457\u20131467","journal-title":"Lab Investig"},{"key":"233_CR1002","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/0016-5085(81)90078-0","volume":"80","author":"FJ Suchy","year":"1981","unstructured":"Suchy FJ, Balistreri WF, Heubi JE et al (1981) Physiologic cholestasis: elevation of the primary serum bile acid concentrations in normal infants. Gastroenterology 80:1037\u20131041","journal-title":"Gastroenterology"},{"key":"233_CR127","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1124\/mol.116.106617","volume":"91","author":"R Sun","year":"2017","unstructured":"Sun R, Yang N, Kong B et al (2017) Orally administered berberine modulates hepatic lipid metabolism by altering microbial bile acid metabolism and the intestinal FXR signaling pathway. Mol Pharmacol 91:110\u2013122","journal-title":"Mol Pharmacol"},{"key":"233_CR128","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","volume":"24","author":"L Sun","year":"2018","unstructured":"Sun L, Xie C, Wang G et al (2018a) Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat Med 24:1919\u20131929","journal-title":"Nat Med"},{"key":"233_CR129","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13238-018-0546-3","volume":"9","author":"L Sun","year":"2018","unstructured":"Sun L, Ma L, Ma Y et al (2018b) Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectives. Protein Cell 9:397\u2013403","journal-title":"Protein Cell"},{"key":"233_CR130","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1194\/jlr.M071183","volume":"57","author":"S Takahashi","year":"2016","unstructured":"Takahashi S, Fukami T, Masuo Y et al (2016) Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans. J Lipid Res 57:2130\u20132137","journal-title":"J Lipid Res"},{"key":"233_CR131","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.clnu.2012.02.009","volume":"31","author":"TF Teixeira","year":"2012","unstructured":"Teixeira TF, Souza NC, Chiarello PG et al (2012) Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr 31:735\u2013740","journal-title":"Clin Nutr"},{"key":"233_CR132","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.tips.2015.04.002","volume":"36","author":"RE Temel","year":"2015","unstructured":"Temel RE, Brown JM (2015) A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion. Trends Pharmacol Sci 36:440\u2013451","journal-title":"Trends Pharmacol Sci"},{"key":"233_CR133","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","volume":"10","author":"C Thomas","year":"2009","unstructured":"Thomas C, Gioiello A, Noriega L et al (2009) TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 10:167\u2013177","journal-title":"Cell Metab"},{"key":"233_CR134","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jcmgh.2016.12.009","volume":"24","author":"CA Thompson","year":"2017","unstructured":"Thompson CA, Wojta K, Pulakanti K et al (2017) GATA4 is sufficient to establish jejunal versus ileal identity in the small intestine. Cell Mol Gastroenterol Hepatol 24:422\u2013446","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"233_CR135","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1389203043486946","volume":"5","author":"J Thulesen","year":"2004","unstructured":"Thulesen J (2004) Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator. Curr Protein Pept Sci 5:51\u201365","journal-title":"Curr Protein Pept Sci"},{"key":"233_CR136","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.cmet.2018.05.023","volume":"28","author":"M Toledo","year":"2018","unstructured":"Toledo M, Batista-Gonzalez A, Merheb E et al (2018) Autophagy regulates the liver clock and glucose metabolism by degrading CRY1. Cell Metab 28:268\u2013281","journal-title":"Cell Metab"},{"key":"233_CR137","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1210\/endo.143.5.8850","volume":"143","author":"E Tomlinson","year":"2002","unstructured":"Tomlinson E, Fu L, John L et al (2002) Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 143:1741\u20131747","journal-title":"Endocrinology"},{"key":"233_CR138","doi-asserted-by":"publisher","first-page":"7629","DOI":"10.1038\/ncomms8629","volume":"6","author":"M-S Trabelsi","year":"2015","unstructured":"Trabelsi M-S, Daoudi M, Prawitt J et al (2015) Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun 6:7629","journal-title":"Nat Commun"},{"key":"233_CR139","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/hep.28991","volume":"65","author":"M Trauner","year":"2017","unstructured":"Trauner M, Fuchs CD, Halilbasic E (2017) New therapeutic concepts in bile acid transport and signaling for management of cholestasis. Hepatology 65:1393\u20131404","journal-title":"Hepatology"},{"key":"233_CR140","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/219683","volume":"2010","author":"RM Uranga","year":"2010","unstructured":"Uranga RM, Keller JN (2010) Diet and age interactions with regards to cholesterol regulation and brain pathogenesis. Curr Gerontol Geriatr Res 2010:219683","journal-title":"Curr Gerontol Geriatr Res"},{"key":"233_CR141","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jcmgh.2017.11.011","volume":"28","author":"SMW van de Wiel","year":"2018","unstructured":"van de Wiel SMW, de Waart DR, Oude Elferink RPJ et al (2018) Intestinal farnesoid X receptor activation by pharmacologic inhibition of the organic solute transporter \u03b1-\u03b2. Cell Mol Gastroenterol Hepatol 28:223\u2013237","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"233_CR142","doi-asserted-by":"publisher","first-page":"10315","DOI":"10.1074\/jbc.M807317200","volume":"284","author":"TH van Dijk","year":"2009","unstructured":"van Dijk TH, Grefhorst A, Oosterveer MH et al (2009) An increased flux through the glucose 6-phosphate pool in enterocytes delays glucose absorption in Fxr\u2212\/\u2212 mice. J Biol Chem 284:10315\u201310323","journal-title":"J Biol Chem"},{"key":"233_CR143","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jhep.2015.03.012","volume":"62","author":"KJ van Erpecum","year":"2015","unstructured":"van Erpecum KJ, Schaap FG (2015) Intestinal failure to produce FGF19: a culprit in intestinal failure-associated liver disease? J Hepatol 62:1231\u20131233","journal-title":"J Hepatol"},{"key":"233_CR144","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.bcp.2013.07.022","volume":"86","author":"J Vaquero","year":"2013","unstructured":"Vaquero J, Monte MJ, Dominguez M et al (2013) Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition. Biochem Pharmacol 86:926\u2013939","journal-title":"Biochem Pharmacol"},{"key":"233_CR145","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.4049\/jimmunol.0803978","volume":"183","author":"P Vavassori","year":"2009","unstructured":"Vavassori P, Mencarelli A, Renga B et al (2009) The bile acid receptor FXR is a modulator of intestinal innate immunity. J Immunol 183:6251\u20136261","journal-title":"J Immunol"},{"key":"233_CR146","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajpath.2014.10.009","volume":"185","author":"L Verbeke","year":"2015","unstructured":"Verbeke L, Farre R, Verbinnen B et al (2015) The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats. Am J Pathol 185:409\u2013419","journal-title":"Am J Pathol"},{"key":"233_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/srep33453","volume":"16","author":"L Verbeke","year":"2016","unstructured":"Verbeke L, Mannaerts I, Schierwagen R et al (2016) FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis. Sci Rep 16:33453","journal-title":"Sci Rep"},{"key":"233_CR148","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/hep.23586","volume":"51","author":"PM Verhulst","year":"2010","unstructured":"Verhulst PM, van der Velden LM, Oorschot V et al (2010) A flippase-independent function of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1, is required for apical protein expression and microvillus formation in polarized epithelial cells. Hepatology 51:2049\u20132060","journal-title":"Hepatology"},{"key":"233_CR149","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1042\/bj3560317","volume":"356","author":"PJ Voshol","year":"2001","unstructured":"Voshol PJ, Schwarz M, Rigotti A et al (2001) Down-regulation of intestinal scavenger receptor class B, type I (SR-BI) expression in rodents under conditions of deficient bile delivery to the intestine. Biochem J 356:317\u2013325","journal-title":"Biochem J"},{"key":"233_CR150","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1074\/mcp.M112.017905","volume":"11","author":"SA Wagner","year":"2012","unstructured":"Wagner SA, Beli P, Weinert BT et al (2012) Proteomic analyses reveal divergent ubiquitylation site patterns in murine tissues. Mol Cell Proteomics 11:1578\u20131585","journal-title":"Mol Cell Proteomics"},{"key":"233_CR151","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1186\/1756-0500-7-902","volume":"11","author":"EM Walker","year":"2014","unstructured":"Walker EM, Thompson CA, Kohlnhofer BM et al (2014) Characterization of the developing small intestine in the absence of either GATA4 or GATA6. BMC Res Notes 11:902","journal-title":"BMC Res Notes"},{"key":"233_CR152","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","volume":"3","author":"H Wang","year":"1999","unstructured":"Wang H, Chen J, Hollister K et al (1999) Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR. Mol Cell 3:543\u2013553","journal-title":"Mol Cell"},{"key":"233_CR153","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/hep.22519","volume":"48","author":"Y-D Wang","year":"2008","unstructured":"Wang Y-D, Chen W, Wang M et al (2008) Farnesoid X receptor antagonizes nuclear factor \u03baB in hepatic inflammatory response. Hepatology 48:1632\u20131643","journal-title":"Hepatology"},{"key":"233_CR154","doi-asserted-by":"publisher","first-page":"12018","DOI":"10.1074\/jbc.C117.794982","volume":"292","author":"XX Wang","year":"2017","unstructured":"Wang XX, Luo Y, Wang D et al (2017) A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice. J Biol Chem 292:12018\u201312024","journal-title":"J Biol Chem"},{"key":"233_CR155","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature04330","volume":"439","author":"M Watanabe","year":"2006","unstructured":"Watanabe M, Houten SM, Mataki C et al (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439:484\u2013489","journal-title":"Nature"},{"key":"233_CR156","doi-asserted-by":"publisher","first-page":"G425","DOI":"10.1152\/ajpgi.00368.2013","volume":"306","author":"SG Wheeler","year":"2014","unstructured":"Wheeler SG, Hammond CL, Jornayvaz FR et al (2014) Ost\u03b1\u2212\/\u2212 mice exhibit altered expression of intestinal lipid absorption genes, resistance to age-related weight gain, and modestly improved insulin sensitivity. Am J Physiol Gastrointest Liver Physiol 306:G425\u2013G438","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"233_CR157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043961","volume":"7","author":"JA Williams","year":"2012","unstructured":"Williams JA, Thomas AM, Li G et al (2012) Tissue specific induction of p62\/Sqstm1 by farnesoid X receptor. PLoS One 7:e43961","journal-title":"PLoS One"},{"key":"233_CR158","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1021\/jm400459m","volume":"56","author":"Y Wu","year":"2013","unstructured":"Wu Y, Aquino CJ, Cowan DJ et al (2013) Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes. J Med Chem 56:5094\u20135114","journal-title":"J Med Chem"},{"key":"233_CR159","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2337\/db16-0663","volume":"66","author":"C Xie","year":"2017","unstructured":"Xie C, Jiang C, Shi J et al (2017) An intestinal farnesoid X receptor-ceramide signaling axis modulates hepatic gluconeogenesis in mice. Diabetes 66:613\u2013626","journal-title":"Diabetes"},{"key":"233_CR160","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jhep.2013.12.003","volume":"60","author":"X Xiong","year":"2014","unstructured":"Xiong X, Wang X, Lu Y et al (2014) Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice. J Hepatol 60:847\u2013854","journal-title":"J Hepatol"},{"key":"233_CR161","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1074\/jbc.M209505200","volume":"278","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Kast-Woelbern HR, Edwards PA (2003) Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation. J Biol Chem 278:104\u2013110","journal-title":"J Biol Chem"},{"key":"233_CR162","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1101\/gad.1138104","volume":"18","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Castellani LW, Sinal CJ et al (2004) Peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 (PGC-1\u03b1) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev 18:157\u2013169","journal-title":"Genes Dev"},{"key":"233_CR1003","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.febslet.2007.11.015","volume":"582","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Edwards PA (2008) FXR signaling in metabolic disease. FEBS Lett 582:10\u201318","journal-title":"FEBS Lett"},{"key":"233_CR163","doi-asserted-by":"publisher","first-page":"e00070","DOI":"10.1128\/mSystems.00070-16","volume":"1","author":"L Zhang","year":"2016","unstructured":"Zhang L, Xie C, Nichols RG et al (2016) Farnesoid X receptor signaling shapes the gut microbiota and controls hepatic lipid metabolism. mSystems 1:e00070\u2013e00016","journal-title":"mSystems"},{"key":"233_CR164","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.jhep.2017.01.027","volume":"66","author":"M Zhou","year":"2017","unstructured":"Zhou M, Luo J, Chen M et al (2017) Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19\/FGF15. J Hepatol 66:1182\u20131192","journal-title":"J Hepatol"},{"key":"233_CR165","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1104\/pp.104.046367","volume":"136","author":"P Zimmermann","year":"2004","unstructured":"Zimmermann P, Hirsch-Hoffmann M, Hennig L et al (2004) GENEVESTIGATOR. Arabidopsis microarray database and analysis toolbox. Plant Physiol 136:2621\u20132632","journal-title":"Plant Physiol"}],"container-title":["Handbook of Experimental Pharmacology","Bile Acids and Their Receptors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2019_233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T16:09:53Z","timestamp":1649952593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2019_233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030220044","9783030220051"],"references-count":169,"URL":"https:\/\/doi.org\/10.1007\/164_2019_233","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"25 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}